Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4results about How to "Induce immune response" patented technology

Human Immunodeficiency Virus Antigens, Vectors, Compositions, and Methods of Use

The invention relates to synthetic HIV envelope proteins, vectors and associated compositions, as well as methods for inducing protective immunity against human immunodeficiency virus (HIV) infection. Viral expression vectors encoding synthetic HIV envelope proteins can be used in vaccines to enhance protective immunity against HIV.
Owner:JANSSEN VACCINES & PREVENTION BV

Application of VdPL9-3 protein in enhancing plant resistance and inducing plant immune responses

ActiveCN115850410Binduce immune responseIncrease resistanceDepsipeptidesFermentation
This invention provides the application of VdPL9-3 protein in improving plant resistance and / or inducing plant immune responses. The amino acid sequence of VdPL9-3 protein is shown in SEQ ID NO.1. It is a highly efficient plant immune activating protein that can effectively improve plant resistance and enhance the host's ability to defend against pathogens.
Owner:INST OF PLANT PROTECTION CHINESE ACAD OF AGRI SCI

Specific t cell epitope peptide screened by novel coronavirus s1, n and m protein proteome and application thereof

ActiveCN120647730Binduce immune responseSsRNA viruses positive-senseViral antigen ingredientsDiseaseCoronavirus vaccination
The application discloses a specific T cell epitope peptide screened by a whole proteome of S1, N and M proteins of a novel coronavirus and application, relates to the technical field of biological medicine, and its technical points are: the application provides a plurality of CD4+ T and CD8+ T cell epitope polypeptides of the novel coronavirus, and the genes, recombinant proteins or complexes containing the epitope polypeptides, sensitized antigen presenting cells and specific immune effector cells for the epitope polypeptides are used in the development of a novel coronavirus vaccine and the treatment of diseases.The polypeptide provided by the application is screened from the peripheral blood sample of a recovered person who breaks through infection of Omicron BA.5 after inactivated vaccine booster vaccination, and can safely and effectively induce CD4+ T and CD8+ T cell immune responses to the novel coronavirus protein, and has important guiding significance for the development of a novel coronavirus vaccine.
Owner:THE NAVAL MEDICAL UNIV OF PLA +1

ANTIGENS, VECTORS, COMPOSITIONS OF THE HUMAN IMMUNODEFICIENCY VIRUS AND THEIR METHODS OF USE

Synthetic HIV envelope proteins, vectors and compositions thereof, and methods for inducing protective immunity against human immunodeficiency virus (HIV) infection are described. Viral expression vectors encoding the synthetic HIV envelope proteins can be used in vaccines to provide improved protective immunity against HIV.
Owner:JANSSEN VACCINES & PREVENTION BV